CEL-SCI CORPORATION Total Liabilities
CEL-SCI CORPORATION (CVM) had Total Liabilities of $10.40 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-14
- 2026-06-30: Liabilities $10.40M.
- 2026-03-31: Liabilities $10.83M.
- 2025-12-31: Liabilities $11.76M.
- 2025-09-30: Liabilities $12.20M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $10.40M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $10.83M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $11.76M 10-Q · filed 2026-02-17 | |
| 2025-09-30 | $12.20M 10-Q · filed 2026-08-14 | |
| 2025-06-30 | $13.31M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $13.81M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $14.39M 10-Q · filed 2025-02-14 | |
| 2024-09-30 | $14.12M 10-K · filed 2025-12-29 | |
| 2024-06-30 | $15.60M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $15.74M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $16.06M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $17.31M 10-K · filed 2025-01-13 | |
| 2023-06-30 | $17.53M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $18.05M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $17.97M 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $18.36M 10-K · filed 2023-12-21 | |
| 2022-06-30 | $18.16M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $19.03M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $18.32M 10-Q · filed 2022-02-11 | |
| 2021-09-30 | $19.34M 10-K · filed 2022-12-27 | |
| 2021-06-30 | $19.85M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $19.03M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $20.78M 10-Q · filed 2021-02-12 | |
| 2020-09-30 | $20.81M 10-K · filed 2021-12-21 | |
| 2020-06-30 | $23.02M 10-Q/A · filed 2020-12-31 | |
| 2020-03-31 | $22.51M 10-Q/A · filed 2020-12-30 | |
| 2019-12-31 | $22.54M 10-Q/A · filed 2020-12-30 | |
| 2019-09-30 | $22.49M 10-Q/A · filed 2020-12-31 | |
| 2019-06-30 | $27.34M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $23.80M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $23.23M 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $29.59M 10-K/A · filed 2019-12-23 | |
| 2018-06-30 | $22.95M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $26.15M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $27.01M 10-Q · filed 2018-02-12 | |
| 2017-09-30 | $26.26M 10-K · filed 2018-12-19 | |
| 2017-06-30 | $26.91M 10-Q/A · filed 2017-12-11 | $13.75M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $24.91M 10-Q/A · filed 2017-12-11 | $11.80M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $18.56M 10-Q/A · filed 2017-12-11 | $5.49M 10-Q · filed 2017-02-09 |
| 2016-09-30 | $25.57M 10-K · filed 2017-12-29 | $12.55M 10-K · filed 2016-12-15 |
| 2016-06-30 | $18.25M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $18.46M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $16.45M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $33.32M 10-K/A · filed 2017-12-11 | $20.68M 10-K · filed 2015-12-11 |
| 2015-06-30 | $17.57M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $12.38M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $7.71M 10-Q · filed 2015-02-06 | |
| 2014-09-30 | $8.79M 10-K · filed 2015-12-11 | |
| 2014-06-30 | $10.12M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $14.46M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $9.69M 10-Q · filed 2014-02-10 | |
| 2013-09-30 | $4.14M 10-K · filed 2014-12-23 | |
| 2013-06-30 | $6.95M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $6.94M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $10.39M 10-Q · filed 2013-02-08 | |
| 2012-09-30 | $9.04M 10-K · filed 2013-12-27 | |
| 2012-06-30 | $10.91M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $12.14M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $8.57M 10-Q · filed 2012-02-09 | |
| 2011-09-30 | $9.55M 10-K · filed 2012-12-14 | |
| 2011-06-30 | $14.56M 10-Q · filed 2011-08-09 | |
| 2010-09-30 | $9.95M 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |